会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 53. 发明申请
    • ANALOGUES OF AN ANTI-THROMBIN POLYPEPTIDE AND PROCESS FOR THEIR PREPARATION
    • 抗凝血多肽的模拟物及其制备方法
    • WO1995003409A1
    • 1995-02-02
    • PCT/EP1994001979
    • 1994-06-17
    • FARMITALIA CARLO ERBA S.R.L.
    • FARMITALIA CARLO ERBA S.R.L.SCACHERI, EmanuelaVISCO, CarloMOLINARI, AntonioGERNA, MarcoBOLIS, Giorgio
    • C12N15/15
    • C07K14/005A61K38/00C07K14/815C07K2319/02C12N2760/20222
    • The present invention relates to analogues of anti-thrombin polypeptides and to a process for their preparation. The analogues have been obtained by a C-terminal modification of anti-thrombin polypeptides isolated from the leech Hirudinaria manillensis and are characterized by an improved biological activity in comparison to the polypeptides from which they are derived. The analogues of the invention may be prepared by: 1) isolating the anti-thrombin polypeptide from the tissue or secretions of the leech Hirudinaria manillensis and 2) subsequently modifying the C-terminal end of such polypeptide. Alternatively, the analogues may also be synthetized by recombinant DNA methods. According to this latter aspect, the invention provides DNA sequences, expression vectors and host cell lines for the recombinant preparation of the analogues. The analogues of the invention find a useful application in the treatment of venous thrombosis, vascular shunt occlusion and thrombin-induced disseminated intravascular coagulation.
    • 本发明涉及抗凝血酶多肽的类似物及其制备方法。 类似物已经通过从水蛭Hirudinaria manillensis分离的抗凝血酶多肽的C末端修饰获得,并且与从其衍生的多肽相比具有改善的生物学活性。 本发明的类似物可以通过以下方法制备:1)从水蛭水蛭属的组织或分泌物中分离抗凝血酶多肽,和2)随后修饰该多肽的C-末端。 或者,类似物也可以通过重组DNA方法合成。 根据后一方面,本发明提供用于重组制备类似物的DNA序列,表达载体和宿主细胞系。 本发明的类似物在治疗静脉血栓形成,血管分流闭塞和凝血酶诱导的弥散性血管内凝血方面发现有用。
    • 54. 发明申请
    • TRICYCLIC DEFEM SULPHONES AS ELASTASE INHIBITORS
    • TRICYCLIC DEFEM SULPHONES as ELASTASE INHIBITORS
    • WO1994028003A1
    • 1994-12-08
    • PCT/EP1994001643
    • 1994-05-17
    • FARMITALIA CARLO ERBA S.R.L.ALPEGIANI, MarcoBISSOLINO, PierluigiPERRONE, EttoreRIZZO, Vincenzo
    • FARMITALIA CARLO ERBA S.R.L.
    • C07D501/00
    • C07D501/00
    • The present invention provides compounds of formula (I) and pharmaceutically or veterinarily salts thereof; wherein R1 is hydrogen or halogen or an organic group; R2 is hydrogen or an optionally substituted C1-C6 alkyl, C3-C6 cycloalkyl, C6-C10 aryl or C7-C14 aralkyl group; R3 is hydrogen or halogen, or an organic group; R4 is hydrogen or a group defined as R2 above or R4 taken together with R3 constitutes a C2-C6 alkanediyl or an alkanediyl radical optionally substituted by methyl or phenyl and X is either oxygen or sulphur or NR6, wherein R6 is either hydrogen or a group as defined for R2. A process for their preparation by cyclization of appropriate intermediates is also described. The compounds of formula (I) and the pharmaceutically and veterinarily acceptable salts thereof are elastase inhibitors.
    • 本发明提供式(I)化合物及其药学上或兽用盐; 其中R1是氢或卤素或有机基团; R 2是氢或任选取代的C 1 -C 6烷基,C 3 -C 6环烷基,C 6 -C 10芳基或C 7 -C 14芳烷基; R3是氢或卤素,或有机基团; R 4是氢或被定义为R 2或R 4与R 3一起构成的基团构成任选被甲基或苯基取代的C 2 -C 6烷二基或烷二基,X是氧或硫或NR 6,其中R 6是氢或基团 如R2所定义。 还描述了通过合适的中间体的环化制备其方法。 式(I)化合物及其药学上和兽医学上可接受的盐是弹性蛋白酶抑制剂。
    • 55. 发明申请
    • SEROTONINERGIC ERGOLINE DERIVATIVES
    • 丝氨酸蛋白衍生物
    • WO1994014806A1
    • 1994-07-07
    • PCT/EP1993003337
    • 1993-11-26
    • FARMITALIA CARLO ERBA S.R.L.
    • FARMITALIA CARLO ERBA S.R.L.MANTEGANI, SergioBRAMBILLA, EnzoCACCIA, CarlaCARFAGNA, Nicola
    • C07D457/04
    • C07D457/04C07D457/02C07D457/08C07D457/12
    • The present invention provides compounds of formula (I) wherein A represents OH, NH2, COOR3', OCONHR4, CONHR4, NHCOR4, NHCO2R4, NHC(X)NHR4, NHC(X)NHCOR4, (a) or (b), R1 is hydrogen or C1-4 linear or branched alkyl; R2 is hydrogen, chlorine, bromine or an S-C1-4 alkyl group; R3 and R3' are, independently, C1-5 alkyl or hydrogen, n is 0,1 or 2, m is 1 or 2; R4 is hydrogen, C1-7 alkyl, C3-7 cycloalkyl, adamantidyl (tricyclo 3.3.1.1. ) decan-1-yl, C1-5 alkylphenyl, C2 alkenylphenyl; C2 alkynylphenyl, phenyl optionally substituted by one or more groups selected from C1-4 alkyl, C1-3 alkoxy, methylendioxy, cyano, trifluoromethyl, hydroxy, nitro and acetyl; an optionally substituted naphthyl ring or phenyl condensed with a heterocyclic ring system having 5- or 6- ring members including 1 to 4 heteroatoms selected from nitrogen, oxygen and sulphur; a heterocyclic ring having 5 or 6 ring members including 1 or 2 heteroatoms selected from nitrogen, oxygen and sulphur which is optionally substituted by a group selected from C1-4 alkyl, phenyl optionally substituted as defined above, C1-3 alkoxy and halogen; R5 is hydrogen, C1-4 alkyl or a phenyl group and X is NH, O, S; or a pharmaceutically acceptable salt thereof. A process for their preparation and the pharmaceutical compositions comprising them are also provided.
    • 本发明提供式(I)化合物,其中A代表OH,NH2,COOR3',OCONHR4,CONHR4,NHCOR4,NHCO2R4,NHC(X)NHR4,NHC(X)NHCOR4,(a)或(b) 氢或C 1-4直链或支链烷基; R2是氢,氯,溴或S-C1-4烷基; R3和R3'独立地为C1-5烷基或氢,n为0,1或2,m为1或2; R4是氢,C1-7烷基,C3-7环烷基,金刚烷基(三环3.3.1.1。<3,7>)癸烷-1-基,C1-5烷基苯基,C2链烯基苯基; C 2炔基苯基,任选被一个或多个选自C 1-4烷基,C 1-3烷氧基,甲氧基,氰基,三氟甲基,羟基,硝基和乙酰基的基团取代的苯基; 任选取代的萘基环或与具有5-或6-个环成员的杂环系统缩合的苯基,包括1至4个选自氮,氧和硫的杂原子; 具有5或6个环成员的杂环,包括1或2个选自氮,氧和硫的杂原子,其任选被选自C 1-4烷基,任选如上所定义的苯基,C 1-3烷氧基和卤素的基团取代; R5是氢,C1-4烷基或苯基,X是NH,O,S; 或其药学上可接受的盐。 还提供了其制备方法和包含它们的药物组合物。
    • 56. 发明申请
    • HYDROXY PROTECTING GROUP REMOVAL IN PENEMS
    • 保护组中的羟基保护基
    • WO1993023406A1
    • 1993-11-25
    • PCT/EP1993000935
    • 1993-04-15
    • FARMITALIA CARLO ERBA S.R.L.
    • FARMITALIA CARLO ERBA S.R.L.BEDESCHI, AngeloZARINI, Franco
    • C07D499/88
    • C07D499/88Y02P20/55
    • The present invention relates to removal of t-butyldimethylsilyl protecting groups in the preparation of penems which are useful antibiotics. The invention provides a process for preparing a compound of formula (I), wherein R is a free or protected hydroxy or amino group or an alkoxy, acyloxy or an optionally substituted carbamoyloxy group, and R1 is selected from: a) hydrogen; b) a C2-C4 alkenyl group; c) a p-NO2 benzyl group; d) a linear or branched alkanoyloxy C1-C2 alkyl group; and e) (2-oxo-1,3-dioxolen-4-yl)methyl optionally substituted by C1-C4 alkyl at the 5-position or a pharmaceutically acceptable salt thereof, which process comprises reacting a compound of formula (II).
    • 本发明涉及在用作抗生素的青霉烯的制备中除去叔丁基二甲基甲硅烷基保护基。 本发明提供了制备式(I)化合物的方法,其中R为游离或保护的羟基或氨基或烷氧基,酰氧基或任选取代的氨基甲酰氧基,R 1选自:a)氢; b)C 2 -C 4烯基; c)p-NO 2苄基; d)直链或支链烷酰氧基C 1 -C 2烷基; 和e)任选被5位的C 1 -C 4烷基取代的(2-氧代-1,3-二氧杂环戊烯-4-基)甲基或其药学上可接受的盐,该方法包括使式(II)化合物反应。